Joel Greenblatt’s NeoGenomics NEO Stock Holding History

Joel Greenblatt’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,765	Closed	-$207K	–	1432
2023 Q4	$207K	Buy	12,765 +1,690	+15%	+$27.7K	﹤0.01%	1244
2023 Q3	$136K	Sell	11,075 -32,092	-74%	-$477K	﹤0.01%	1270
2023 Q2	$694K	Buy	43,167 +32,171	+293%	+$530K	0.02%	876
2023 Q1	$191K	Buy	+10,996	New	+$157K	﹤0.01%	1252
2019 Q1	–	Sell	-23,378	Closed	-$295K	–	1214
2018 Q4	$295K	Buy	+23,378	New	+$348K	﹤0.01%	865
2018 Q3	–	Sell	-11,024	Closed	-$145K	–	989
2018 Q2	$145K	Buy	+11,024	New	+$121K	﹤0.01%	851
2017 Q2	–	Sell	-14,920	Closed	-$118K	–	1047
2017 Q1	$118K	Sell	14,920 -4,782	-24%	-$39K	﹤0.01%	951
2016 Q4	$169K	Sell	19,702 -4,701	-19%	-$40.3K	﹤0.01%	897
2016 Q3	$201K	Sell	24,403 -1,351	-5%	-$11.3K	﹤0.01%	870
2016 Q2	$207K	Buy	+25,754	New	+$206K	﹤0.01%	884

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Joel Greenblatt's NEO Position: Q1 2024 in Review

Joel Greenblatt sold out of NeoGenomics (NEO) in Q1 2024, closing a stake of 12,765 shares — an estimated $207K sold.

Joel Greenblatt first reported a position in NEO in Q2 2016 and held it in 10 quarters. The position peaked at $694K in Q2 2023. 263 funds tracked by Wall St. Rank hold NEO as of Q1 2024.

Joel Greenblatt reported no remaining NeoGenomics position as of Q1 2024 after selling out during the quarter.
Joel Greenblatt sold 12,765 NeoGenomics shares in Q1 2024, an estimated $207K.
Joel Greenblatt first reported a position in NeoGenomics in Q2 2016 and held it in 10 quarters.
Joel Greenblatt's NeoGenomics position peaked at $694K in Q2 2023.
263 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2024.

Based on Gotham Asset Management's 13F filing for Q1 2024, filed 15 May 2024.